New Technologies for Viral Hepatitis STTR (R41/R42)

The following funding information has been recently added to the CDC National Prevention Information Network’s (NPIN) Funding Database (http://npin.cdc.gov/search/funding).

Centers for Medicare and Medicaid Services CMS

Fund Number

4922

Fund Title

New Technologies for Viral Hepatitis STTR (R41/R42)

Fund Category

Other Health-Related

Description

This FOA encourages small business establishments to submit applications that address any of the specific research topics in the updated Action Plan for the Prevention, Care & Treatment of Viral Hepatitis that are assigned to the NIH and germane to the research mission of the respective NIH Institutes and Centers.

Sponsor(s)

  • US Department of Health and Human Services
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

— AND —

  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

— AND —

  • US Department of Health and Human Services
  • Public Health Service
  • National Institutes of Health

— AND —

  • National Heart Lung and Blood Institute

 

Funder’s Fund ID

PA-15-076

Additional Details

Application Due Date: 01/07/2018 Earliest submission date 03/05/2015

Fund Duration: Not exceed 1 year for Phase I. Not exceed 2 years for Phase II.

Application Process: Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.

It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf), except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Award Notes: According to statutory guidelines, total funding support normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. Applicants are encouraged to propose a budget that is reasonable and appropriate for completion of the research project.

Eligible Locations: National

Fund Notes: If the application is AIDS-related, please see http://grants.nih.gov/grants/funding/submissionschedule.htm#AIDS.

Application Contact Name: Christine Densmore
Title: Program Director
Application Contact Address: 

NIDDK
6707 Democracy Blvd, Rm 649
Bethesda, MD 208925450
United States

Technical Contact Name: Jennifer Cho
Technical Contact Address:

NIDDK
6707 Democracy Blvd, Rm 649
Bethesda, MD 208925450
United States

Support Types: Research

Subject Areas:

  • Diagnostic Tests
  • Hepatitis Prevention
  • Medical Treatments and Therapies
  • Research Programs

Audiences: Researchers

Eligibility: Commercial Organizations

Eligibility Notes:
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria:

  1. Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor;
  2. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there can be no more than 49 percent participation by foreign business entities in the joint venture;
  3. Is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, except in the case of a joint venture, where each entity to the venture must be 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States; and;
  4. Has, including its affiliates, not more than 500 employees.

SBCs must also meet the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns, other than investment companies licensed, or state development companies qualifying under the Small Business Investment Act of 1958, 15 U.S.C. 661, et seq., are affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Business concerns include, but are not limited to, any individual (sole proprietorship) partnership, corporation, joint venture, association, or cooperative. The SF424 (R&R) SBIR/STTR Application Guide should be referenced for detailed eligibility information.

Foreign Institutions:

  • Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
  • Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
  • Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Tags:

©2019 HepFree.NYC. All rights reserved. Site by Lookit Design QuikSite®

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you. Thank you.

Sending
or

Log in with your credentials

Forgot your details?